News » Dispensary guidance news » Creon goes solo with Alliance
March 3rd 2025
Viatris UK has announced that, from 1 March 2025, all orders of licensed Creon® preparations should be placed directly with Alliance Healthcare UK.
This is a shift away from the current three-wholesaler (AAH, Alliance Healthcare UK and Phoenix) distribution model to using only Alliance Healthcare UK as the sole distributor of licensed Creon® preparations in the UK.
The details of the products covered by the new distribution arrangements are included in the table below.
|
Product |
Price |
Pip Code |
|
Creon® 10000 gastro-resistant capsules (100) |
£12.93 |
2291847 |
|
Creon® 25000 gastro-resistant capsules (100) |
£28.25 |
2553436 |
|
Creon® Micro Pancreatin 60.12mg gastro-resistant granules (20g) |
£31.50 |
3023231 |
Viatris UK believes this change will support the optimal distribution of licensed Creon® preparations to healthcare providers across the UK.
For any questions or for further information about the new supply arrangements, contact the dedicated Creon® customer support line on 0800 8086410 (open Monday to Friday between 9:00 to 17:00).
In December 2024, a National Patient Safety Alert (NPSA) for Shortage of Pancreatic enzyme replacement therapy (PERT) was published highlighting that Creon® will remain in limited supply until 2026 and alternatives such as Nutrizym® 22 capsules and Pancrex V® capsules and powder are intermittently available but are unable to fully cover the gap in supply.